← Leaderboards
Michael Kharas
Sloan-Kettering Inst Can Research
$18,485,709
Attributed
$24,767,448
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,767,448 · 8
By mechanism
R01$23,983,131 · 7
K01$784,317 · 1
Top collaborators
- Samie R Jaffrey9 shared
- Kayvan R Keshari6 shared
- Eirini Papapetrou5 shared
- Eric C Lai4 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Kayvan R Keshari$12,246,491
- Jiangbin Ye$862,286
- Kojo Seys Elenitoba-Johnson$15,478,914
- Eric C Lai$23,049,393
- Nermin Sumru Bayin$188,136
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsProgramsMediatingStem CellsMalignant NeoplasmsInsightLeukemiaPathway InteractionsRegulationOverexpressionMessenger RnaProteinsHematopoieticBaseHematopoietic Stem CellsSelf-RenewalMolecularFamilyBloodMouse ModelPathogenesisAcute Myelocytic LeukemiaGeneticRna-Binding Proteins
Grant awards (54)
Interrogation of the oxidative-stress-induced leukemia program in vivo using metabolic imaging$711,338
R01 · FY2025 · CA
Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma$694,643
R01 · FY2025 · CA · contact PI
Mechanisms of epitranscriptomic regulation in cancer$605,929
R01 · FY2025 · CA
Characterizing the MSI2 network in leukemia$413,245
R01 · FY2025 · CA · contact PI
Interrogation of the oxidative-stress-induced leukemia program in vivo using metabolic imaging$92,576
R01 · FY2025 · CA
Interrogation of the oxidative-stress-induced leukemia program in vivo using metabolic imaging$679,961
R01 · FY2024 · CA
Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma$659,913
R01 · FY2024 · CA · contact PI
Mechanisms of epitranscriptomic regulation in cancer$623,304
R01 · FY2024 · CA
Uncovering the role for MSI2 network in hematopoietic stem cells$607,423
R01 · FY2024 · DK · contact PI
Characterizing the MSI2 network in leukemia$392,583
R01 · FY2024 · CA · contact PI
Interrogation of the oxidative-stress-induced leukemia program in vivo using metabolic imaging$87,947
R01 · FY2024 · CA
Interrogation of the oxidative-stress-induced leukemia program in vivo usingmetabolic imaging$35,552
R01 · FY2024 · CA
Interrogation of the oxidative-stress-induced leukemia program in vivo using metabolic imaging$728,079
R01 · FY2023 · CA
Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma$713,895
R01 · FY2023 · CA · contact PI
Uncovering the role for MSI2 network in hematopoietic stem cells$632,731
R01 · FY2023 · DK · contact PI
Mechanisms and functions of N6-methyladenosine (m6A) in cancer$550,845
R01 · FY2023 · CA
Characterizing the MSI2 network in leukemia$404,981
R01 · FY2023 · CA · contact PI
Identification of therapeutic targets for leukemia stem cells in AML-iPSC models$652,184
R01 · FY2022 · CA
Uncovering the role for MSI2 network in hematopoietic stem cells$632,731
R01 · FY2022 · DK · contact PI
Mechanisms and functions of N6-methyladenosine (m6A) in cancer$550,845
R01 · FY2022 · CA
Characterizing the MSI2 network in leukemia$404,981
R01 · FY2022 · CA · contact PI
Identification of therapeutic targets for leukemia stem cells in AML-iPSC models$654,506
R01 · FY2021 · CA
Uncovering the role for MSI2 network in hematopoietic stem cells$632,731
R01 · FY2021 · DK · contact PI
Mechanisms and functions of N6-methyladenosine (m6A) in cancer$562,086
R01 · FY2021 · CA
Characterizing the MSI2 network in leukemia$413,245
R01 · FY2021 · CA · contact PI
Mechanisms and functions of N6-methyladenosine (m6A) in cancer$24,437
R01 · FY2021 · CA
Molecular and genetic analysis of novel Slicer-dependent miRNA pathways in blood$732,071
R01 · FY2020 · HL
Identification of therapeutic targets for leukemia stem cells in AML-iPSC models$658,908
R01 · FY2020 · CA
Mechanisms and functions of N6-methyladenosine (m6A) in cancer$642,546
R01 · FY2020 · CA
Uncovering the role for MSI2 network in hematopoietic stem cells$632,731
R01 · FY2020 · DK · contact PI
Mechanisms and functions of N6-methyladenosine (m6A) in cancer$49,919
R01 · FY2020 · CA
Molecular and genetic analysis of novel Slicer-dependent miRNA pathways in blood$732,071
R01 · FY2019 · HL
Identification of therapeutic targets for leukemia stem cells in AML-iPSC models$586,205
R01 · FY2019 · CA
Mechanisms and functions of N6-methyladenosine (m6A) in cancer$579,461
R01 · FY2019 · CA
Characterizing MSI2 in leukemia$410,846
R01 · FY2019 · CA · contact PI
Molecular and genetic analysis of novel Slicer-dependent miRNA pathways in blood$698,647
R01 · FY2018 · HL
Identification of therapeutic targets for leukemia stem cells in AML-iPSC models$625,414
R01 · FY2018 · CA
Characterizing MSI2 in leukemia$414,827
R01 · FY2018 · CA · contact PI
Uncovering the role for Msi2 in hematopoietic stem cells$395,775
R01 · FY2018 · DK · contact PI
Molecular and genetic analysis of novel Slicer-dependent miRNA pathways in blood$698,647
R01 · FY2017 · HL
Uncovering the role for Msi2 in hematopoietic stem cells$463,075
R01 · FY2017 · DK · contact PI
Characterizing MSI2 in leukemia$414,827
R01 · FY2017 · CA · contact PI
Characterizing MSI2 in leukemia$414,827
R01 · FY2016 · CA · contact PI
Uncovering the role for Msi2 in hematopoietic stem cells$395,775
R01 · FY2016 · DK · contact PI
Uncovering the role for Msi2 in hematopoietic stem cells$68,560
R01 · FY2016 · DK · contact PI
Characterizing MSI2 in leukemia$414,827
R01 · FY2015 · CA · contact PI
Uncovering the role for Msi2 in hematopoietic stem cells$395,775
R01 · FY2015 · DK · contact PI
Uncovering the role for Msi2 in hematopoietic stem cells$394,706
R01 · FY2014 · DK · contact PI
The role of the Musashi family in hematopoiesis$158,706
K01 · FY2013 · DK · contact PI
The role of the Musashi family in hematopoiesis$158,706
K01 · FY2012 · DK · contact PI
The role of the Musashi family in hematopoiesis$102,600
K01 · FY2011 · DK · contact PI
The role of the Musashi family in hematopoiesis$56,329
K01 · FY2011 · DK · contact PI
The role of the Musashi family in hematopoiesis$157,957
K01 · FY2010 · DK · contact PI
The role of the Musashi family in hematopoiesis$150,019
K01 · FY2009 · DK · contact PI